Difficult days for big pharma

The pharmaceutical industry, it seems, is under almost constant attack at the moment. If it is not Novartis being criticised for its current legal action over India's patent laws, it is the Thai government threatening compulsory licensing on a great…

Get unlimited access to all IAM content